Haleon plc’s (LON:HLN) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

With its stock down 5.1% over the past month, it is easy to disregard Haleon (LON:HLN). But if you pay close attention, you might find that its key financial indicators look quite decent, which could mean that the stock could potentially rise in the long-term given how markets usually reward more resilient long-term fundamentals. In this article, we decided to focus on Haleon’s ROE.

ROE or return on equity is a useful tool to assess how effectively a company can generate returns on the investment it received from its shareholders. Put another way, it reveals the company’s success at turning shareholder investments into profits.

AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10bn in marketcap – there is still time to get in early.

The formula for return on equity is:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders’ Equity

So, based on the above formula, the ROE for Haleon is:

9.6% = UK£1.5b ÷ UK£16b (Based on the trailing twelve months to June 2025).

The ‘return’ refers to a company’s earnings over the last year. One way to conceptualize this is that for each £1 of shareholders’ capital it has, the company made £0.10 in profit.

View our latest analysis for Haleon

So far, we’ve learned that ROE is a measure of a company’s profitability. We now need to evaluate how much profit the company reinvests or “retains” for future growth which then gives us an idea about the growth potential of the company. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don’t share these attributes.

When you first look at it, Haleon’s ROE doesn’t look that attractive. We then compared the company’s ROE to the broader industry and were disappointed to see that the ROE is lower than the industry average of 15%. Hence, the flat earnings seen by Haleon over the past five years could probably be the result of it having a lower ROE.

Next, on comparing Haleon’s net income growth with the industry, we found that the company’s reported growth is similar to the industry average growth rate of 0.9% over the last few years.

Earnings growth is an important metric to consider when valuing a stock. What investors need to determine next is if the expected earnings growth, or the lack of it, is already built into the share price. Doing so will help them establish if the stock’s future looks promising or ominous. Has the market priced in the future outlook for HLN? You can find out in our latest intrinsic value infographic research report.